Literature DB >> 11413386

Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.

Marco Vignuzzi1, Sylvie Gerbaud1, Sylvie van der Werf1, Nicolas Escriou1.   

Abstract

The potential of RNA-based vaccines was evaluated for the generation of a protective immune response in the mouse model of influenza type A virus infection using the internal nucleoprotein (NP) as antigen. This antigen is of particular interest, since it has the potential to elicit protective cytotoxic T lymphocytes (CTL) against heterologous strains of influenza A virus. In view of the short half-life of RNA, self-replicating RNAs or replicons of the positive-stranded genomes of Semliki Forest virus (SFV) and poliovirus were engineered to synthesize the influenza A virus NP in place of their structural proteins. NP expression was demonstrated by immunoprecipitation after transfection of cells with RNA from the SFV (rSFV-NP) and poliovirus (rDeltaP1-E-NP) genome-derived replicons transcribed in vitro. C57BL/6 mice were injected intramuscularly with these synthetic RNAs in naked form. Both replicons, rSFV-NP and rDeltaP1-E-NP, induced antibodies against the influenza virus NP, but only mice immunized with the rSFV-NP replicon developed a CTL response against the immunodominant H-2D(b) epitope NP366. Finally, the protective potential of the CTL response induced by immunization of mice with rSFV-NP RNA was demonstrated by the reduction of virus load in the lungs after challenge infection with mouse-adapted influenza A/PR/8/34 virus and was comparable to the protective potential of the response induced by plasmid DNA immunization. These results demonstrate that naked RNA immunization with self-replicating molecules can effectively induce both humoral and cellular immune responses and constitutes an alternative strategy to DNA immunization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413386     DOI: 10.1099/0022-1317-82-7-1737

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.

Authors:  Itaru Anraku; Tracey J Harvey; Richard Linedale; Joy Gardner; David Harrich; Andreas Suhrbier; Alexander A Khromykh
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Expression of a membrane-anchored glycoprotein, the influenza virus hemagglutinin, by dicistronic replicons derived from the poliovirus genome.

Authors:  Marco Vignuzzi; Sylvie Gerbaud; Sylvie van der Werf; Nicolas Escriou
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 3.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle.

Authors:  Sergiy V Avilov; Dorothée Moisy; Sandie Munier; Oliver Schraidt; Nadia Naffakh; Stephen Cusack
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Enhanced gene silencing in cells cured of persistent virus infection by RNA interference.

Authors:  Isabelle Pelletier; Aure Saulnier; Cynthia Brisac; Sophie Jegouic; Nicolas Vabret; Frédéric Tangy; Bruno Blondel; Florence Colbère-Garapin
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

6.  Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.

Authors:  Judith H Aberle; Stephan W Aberle; Regina M Kofler; Christian W Mandl
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 7.  Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".

Authors:  Kimberly A Schoenly; David B Weiner
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

9.  Long-term storage of DNA-free RNA for use in vaccine studies.

Authors:  Kathryn L Jones; Debbie Drane; Eric J Gowans
Journal:  Biotechniques       Date:  2007-11       Impact factor: 1.993

10.  Avian Influenza A virus polymerase association with nucleoprotein, but not polymerase assembly, is impaired in human cells during the course of infection.

Authors:  Marie-Anne Rameix-Welti; Andru Tomoiu; Emmanuel Dos Santos Afonso; Sylvie van der Werf; Nadia Naffakh
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.